HomeOpen Access NewsDrug Development

Drug Development

Subscribe to Updates

Historic US-UK deal to accelerate AI drug discovery, quantum and nuclear research

Pharma
A new US-UK tech prosperity deal will accelerate AI drug discovery with significant investment in quantum and nuclear.

Finding innovative ways to deal with bacteria

Research & Innovation
Professor of Evolutionary Biology Ashleigh S. Griffin discusses harnessing the power of evolutionary process instead of fighting it, particularly regarding bacterial cells and cooperation.

Drug with the ability to reprogramme aggressive brain tumours 

Cancer Research
Study shows L-methylfolate, when administered alongside standard therapy for glioblastomas, changed the DNA process within a patients tumour

Combining AI tech with drug development efforts

Research & Innovation
Can Artificial Intelligence (AI) change the process of drug development for the pharmaceutical industry?

BioNTech will ship mobile mRNA vaccine factories to Africa

Research & Innovation
BioNTech reveal plans to ship mobile mRNA vaccine factories to some countries in Africa - with vaccine manufacturing expected only in late 2023.

Treating multi-drug resistant tuberculosis

Research & Innovation
Andrew Nunn, Professor of Epidemiology, Medical Research Council Clinical Trials Unit at UCL, describes the first phase 3 trial of a shortened treatment for MDR-TB.

New potential therapy for aggressive bladder cancer

Cancer Research
Led by Yale Cancer Center, new research shows that enfortumab vedotin is an effective alternative for patients with muscle-invasive bladder cancer (MIBC)

Medical cannabis-based treatments: Research, production & distribution

Pharma
Prof Trevor M Jones charts the priorities for research and development, production and distribution of medical cannabis-based treatments

The UK’s doomed Medical Cannabis (Access) Bill

Pharma
Senior Associate, David Hardstaff and Partner, John Binns of BCL Solicitors LLP, explore the UK’s doomed Medical Cannabis (Access) Bill

Drug gives 34% protection against lung cancer recurrence

Cancer Research
The NHS have gained a new drug, atezolizumab, which can give 34% protection against lung cancer recurrence or death, post-chemotherapy.

Secrets of the immune system could help unlock future MS treatments

Diseases & Conditions
Researchers have identified why certain cells in the body, known as Th17 cells can go rogue and promote the onset of MS

New data finds COVID vaccines do not create infertility

Health & Social Care
According to the Boston University School of Public Health, there is no link between COVID vaccination and fertility.

New gene-silencing drug could help with ALS

Diseases & Conditions
New research suggests that in suppressing a mutated ALS gene, it may be possible to delay to onset of symptoms.

Research shows Omicron has 37 mutations on spike protein

Research & Innovation
Omicron appears to have 37 mutations on the spike protein, which is three to five times more than other variants.

Antimicrobial resistance now kills more people than HIV or malaria

Pharma
According to a new study in The Lancet, antimicrobial resistance is now a leading cause of death worldwide, higher than HIV/AIDS or malaria.

WHO supports two new drugs for COVID-19 treatment

Health & Social Care
The two drugs, tested across seven trials on 4,000 COVID patients, can protect the immune system from overloading and lessen chances of ventilation.

Potential kidney damage from long-term use of blood pressure drugs

Health & Social Care
Research from the University of Virginia School of Medicine brings attention to the dangers of long-term use of blood pressure medication
1...789...11Page 8 of 11

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders

Visit Article Archive
Open Access Government

Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.

Follow Us

Resources

Quick Links

Legal & Marketing

As a Crossref Sponsored Member we are able to connect your content with a global network of online scholarly research, currently over 20,000 other organizational members from 160 countries. Crossref drive metadata exchange and support nearly 2 billion monthly API queries, facilitating global research communication.

© Adjacent Digital Politics Ltd